Plant Based Vaccines Antibodies and Biologics (PBVAB 2024) is a conference that covers topics such as:
- Plant-based protein expression systems
- Global need for vaccines and antibodies that can address large, cost-sensitive markets
- Plant viral vector expression systems
- Molecular pharming issues
- Production and scale-up
- Plant-derived antigens & adjuvants
- Purification and GHP manufacture
- Plant-derived antibodies with infectious agent targets/new targets
- Biofuels
- Regulatory control
- Delivery systems
- Containment strategies (physical/genetic)
- Preventing pathogen transmission across mucosal surfaces
- Biofortification
- Clinical trials
- Downstream processing issues
- Biosafety/regulatory/public health issues
Plant Based Vaccines Antibodies and Biologics (PBVAB 2024) brings together:
- Clinicians
- Researchers
- Regulatory/public health organizations
- Representatives from academia, industry and government
- Representatives from the veterinary, human and plant communities with an interest in immunology, vaccinology and biotechnology
Plant Based Vaccines Antibodies and Biologics (PBVAB 2024) might be held in Oct 2024.